SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-311369
Filing Date
2021-10-28
Accepted
2021-10-28 16:30:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d199789dsc13d.htm SC 13D 49496
2 EX-99.1 d199789dex991.htm EX-99.1 209074
  Complete submission text file 0001193125-21-311369.txt   260318
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filed by) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Subject) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92968 | Film No.: 211358754
SIC: 2836 Biological Products, (No Diagnostic Substances)